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Abstract
Background: The aim of this study was to assess the frequency of all-cause rehospitaliza-
tion and due to atrial fibrillation/flutter (AF/AFl), repeat ablation of AF/AFl, mortality within  
30 days and 1-year follow-up in patients after AF/AFl ablation procedure.
Methods: Using data from the National Health Fund we identified a database comprising 
2,022 patients who underwent AF/AFl ablation between January, 2012 and December, 2012 in 
Poland. The primary endpoint was readmission to hospital with discharge diagnosis AF/AFl.  
The secondary endpoints included: repeat AF/AFl ablation, cardiovascular hospitalization, 
all-cause hospitalization, all-cause mortality assessed in 30-day and 1-year time frame.
Results: The mean age was 58.6 ± 10.9 years (66.8% male). The mean time of the index 
ablation hospitalization was 3.8 ± 2.6 days. After discharge, 123 (6.1%) and 540 (26.7%) 
patients were hospitalized because of AF/AFl within 30 days and 1 year, respectively. During 
1-year follow-up, 192 (9.5%) patients underwent subsequent AF/AFl ablations. The patients 
that underwent the second ablation were younger (56.6 ± 11.0 vs. 59.1 ± 10.8; p = 0.019) 
and the time of the index hospitalization was shorter (3.75 ± 2.16 vs. 4.45 ± 3.26; p = 0.03).  
Within 30 days 194 (9.6%) patients were hospitalized and 747 (36.9%) in 1-year follow-up. 
All-cause mortality was 0.1% and 1.4% in 30-day and 1-year follow-up, respectively. In  
a 1-year follow-up patients hospitalized from AF/AFl recurrence were more frequently hospital-
ized due to cardiovascular diseases other than AF/AFl (9.6% vs. 6.7%; p = 0.026), especially 
due to hypertension (2.9% vs. 0.7%; p < 0.001).
Conclusions: Over 1 out of 4 patients who underwent AF/AFl ablation were hospitalized due 
to arrhythmia recurrence in 1 year. (Cardiol J 2015; 22, 6: 630–636)
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Introduction
Atrial fibrillation (AF), the most frequent sus-
tained arrhythmia, is a growing clinical problem. 
It is estimated that prevalence of AF will rise at 
least 2.5-fold by the 2050 [1]. At the same time, the 
number of AF ablation procedures is increasing [2]. 
Despite the better patient selection and novel 
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techniques, the effectiveness of this procedure is 
still unsatisfactory, resulting in a significant rate of 
AF recurrence and repeat ablation procedure [3].
Most of the data about follow-up of patients 
undergoing AF ablation derive from clinical trials 
conducted in selected centers with considerable 
experience in catheter procedures. However, it is 
well-known that clinical trial results do not repre-
sent well daily clinical practice, especially in the low 
volume, non-university centers. On the other hand, 
observational studies are often limited to single 
center observations of small populations. Moreover, 
there is a paucity of data regarding the recurrent hos-
pitalization and repeat ablation in a routine practice. 
Therefore, there is clear need to establish multicenter 
or national registries which should provide accurate 
and robust data about AF ablation recipients.
The aim of the present study was to demon-
strate the clinical evolution of AF ablation patients 
in Poland. We analyzed the follow-up of patients 
who were discharged after AF ablation procedure. 
We investigated AF recurrence, repeat AF ablation, 
hospitalization and mortality within 30 days and 
a 1-year follow-up after the index procedure using 
data from the Polish National Health Fund (NHF).
Methods
Data sources
Data on patients admitted to Polish hospitals 
for an atrial fibrillation/atrial flutter (AF/AFl) 
ablation procedure were derived from NHF. All 
admissions to Polish hospitals are registered in 
the Polish NHF. Admissions are coded with at least 
one primary diagnosis at discharge according to the 
International Classification of Diseases (ICD-10). 
The NHF holds information about the primary dis-
charge diagnosis and procedures performed during 
hospitalization. Information on ablation procedure 
was retrieved from the National Patient Registry. 
All causes for hospitalizations are reported in order 
to get reimbursement from Polish NHF. Mortality 
derived from the national PESEL database (Na-
tional Electronic System of Population Records). 
No data about patients’ comorbidities before the 
index procedure were available.
Study population
Our study population comprised of all patients 
admitted to Polish hospitals with AF/AFl diagno-
sis (ICD-10 – I48) in order to perform procedure 
heart disturbances ablation with electroanatomi-
cal system (E41 according to Diagnosis Related 
Groups [DRG]) or AF balloon cryoablation (E45 
according to DRG) in 2012. AF was diagnosed by 
the electrocardiogram (ECG) monitoring. Patients 
with AFl have the same ICD-10 code as AF patients 
(I48), and, therefore, AFl cases were included. AF 
management and ablation procedure were per-
formed according to the current European Society 
of Cardiology guidelines [4]. All the patients were 
followed precisely for 1 year from discharge after 
the index procedure. No patient was lost to follow-
up. Study protocol was approved by the Regional 
Ethics Committee. Index procedure was defined 
as first hospitalization in 2012 in order to perform 
AF/AFl ablation with electroanatomical system or 
balloon cryoablation.
Endpoints
The primary endpoint was readmission to 
hospital with discharge diagnosis “atrial fibrillation/ 
/flutter”. The secondary endpoints included: repeat 
AF/AFl ablation, cardiovascular hospitalization, all-
cause hospitalization, all-cause mortality. Data on 
patient hospitalizations and survival were collected 
for 365 days. Each patient was observed for 1 year 
after discharge. All the endpoints were assessed 
in 30-day and a 1-year time frame. Cardiovascular 
hospitalizations were defined in accordance with 
DRG: E — heart disease, Q — vascular diseases 
and thromboembolic complications (stroke, ve-
nous thromboembolism). Hospitalizations due to 
coronary artery disease (including acute coronary 
syndromes), hypertension, heart failure (HF), and 
pacemaker implantation were recorded. AF/AFl 
hospitalizations were calculated separately.
Statistics
Continuous data are presented as mean ± 
± standard deviation; those without normal dis-
tribution as median (interquartile range [IQR]). 
Categorical variables are presented as frequencies 
with percentages. Comparisons between groups 
were performed using a 2-tailed, paired or unpaired 
Student’s t-test, U-Mann Whitney test for data with 
distribution other than normal, c2-test and Fisher’s 
exact test as applicable. A p < 0.05 was considered 
statistically significant. Statistical analyses were 




We identified 2,022 patients from the NHF 
database who underwent AF/AFl ablation between 
January 1, 2012, and December 31, 2012 in Poland. 
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Approximately one third of the patients were fe-
male. The mean age was 58.6 ± 10.9 years. The 
mean time of the index ablation hospitalization was 
3.8 ± 2.6 days. In 2012, 2,101 AF/AFl ablations 
were performed (1.04 procedure per patient). AF/ 
/AFl radiofrequency (RF) ablation with electroana-
tomical system was performed in 1,552 (76.8%) 
patients and AF cryoballoon ablation in 470 (23.2%) 
patients. Follow-up time for all patients was 365 
days. The baseline characteristics of the study 
group is presented in Table 1.
AF/AFl hospitalization (primary endpoint) 
One hundred and twenty-three patients (6.1%) 
were hospitalized due to AF/AFl within 30 days. 
One hundred and nine were hospitalized once, 
13 — twice, 1 — three times. There were 138 
hospitalizations because of AF/AFl. AF/AFl was 
the most frequent discharge diagnosis in patients 
hospitalized within 30 days after the index hospi-
talization and it was present in 63.3%.
In a 1-year follow-up, 540 (26.7%) patients 
were hospitalized due to AF/AFl. Three hundred 
and fifty-one were hospitalized once, 108 patients 
— twice, 47 — 3 times, 34 — at least 4 times. 
There were 879 hospitalizations because of AF/AFl 
(which contributed to 64.2% of all 1,369 hospitali-
zations in 1 year). AF/AFl was the most frequent 
diagnosis at discharge in patients hospitalized 
within 1 year after the index hospitalization. Most 
frequent discharge diagnoses of rehospitalization 
are presented in Table 2.
AF/AFl hospitalization vs. no AF/AFl  
hospitalization in a 1-year follow-up 
Five hundred and forty (26.7%) patients were 
hospitalized with discharge diagnosis AF/AFl with-
in 1 year after the index hospitalization. There were 
no differences between this group and patients who 
were not rehospitalized with discharge diagnosis AF/ 
/AFl in terms of age (58.21 ± 10.87 vs. 58.77 ± 10.95; 
p = 0.35) or gender (male 63.7% vs. 67.9%; p = 0.07) 
(Table 3). Index hospitalizations of patients rehos-
pitalized due to AF/AFl lasted longer (4.06 ± 2.5 
vs. 3.8 ± 2.66 days; p = 0.001). In 1-year follow-up, 
patients who were hospitalized because of AF/AFl 
recurrence were also more frequently hospitalized 
due to other cardiovascular diseases than patients 
without subsequent AF/AFl hospitalization (9.6% 
vs. 6.7%; p = 0.026). Recurrences of arrhythmia 
were as common after RF ablation as they were 
after cryoballoon ablation (27.3% vs. 24.8%; p = 
= 0.311). Patients rehospitalized because of AF/ 
/AFl were more frequently hospitalized due to 
hypertension (2.9% vs. 0.7%; p < 0.001). There 
were no differences between the groups regarding 
frequencies of hospitalization due to thromboem-
bolism (p = 0.185), stroke (p = 0.11), coronary 
artery disease (p = 0.378) or HF (p = 0.446) in 
1-year follow-up (Table 3).
AF/AFl hospitalization vs. no AF/AFl  
hospitalization in 30-day observation 
We compared patients who were hospitalized 
due to AF/AFl (n = 123) in 30 days with the rest of 
the population (n = 1,899). There were no differ-
ences regarding gender (p = 0.07) or type of ablation 
(p = 0.756). There was no relation between AF/ 
/AFl hospitalization in 30 days and 1-year mortality 
(1.4% vs. 1.6%; p = 0.854). Patients with AF/AFl 
hospitalizations within 30 days of index ablation 
were more frequently hospitalized due to HF within 
Table 1. Baseline characteristics.
Number of patients 2,022
Males 1,351 (66.8%)
Mean age [years] 58.6 ± 10.9
Mean hospitalization time [days] 3.8 ± 2.6




Radiofrequency ablation 1,616 (76.9%)
Number of index ablation: 2,022
Cryoablation 470 (23.2%)
Radiofrequency ablation 1,552 (76.8%)
Table 2. Discharge diagnosis in patients hospi-
talized in a 1-year follow-up.
Number of patients hospitalized  
in 1 year
747 (36.9%)
Number of patients hospitalized  
with discharge diagnosis:
Atrial fibrillation/flutter 540 (26.7%)
Coronary artery disease: 60 (3.0%)
Treated interventionally 35 (1.7%)
Treated conservatively 25 (1.2%)
Heart failure 51 (2.5%)
Hypertension 27 (1.3%)
Vascular disease 16 (0.8%)
Thromboembolism: 11 (0.5%)
Stroke 7 (0.4%)
Venous thromboembolism 4 (0.2%)
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1 year from ablation (4.1% vs. 1.2%; p = 0.006). 
Patients with AF/AFl hospitalizations within 
30 days after the index hospitalization were more 
likely to undergo subsequent ablation within 
1 year compared with the rest of the population 
(22.8% vs. 8.6%; p < 0.001). The index hospi-
talization of patients who were hospitalized in 
30 days because of AF/AFl was longer than mean 
hospitalization time of the rest of the population 
(4.42 ± 2.83 vs. 3.8 ± 2.61; p = 0.003). There 
was a significant correlation between patients 
who were hospitalized because of AF/AFl within 
30 days and AF/AFl hospitalizations in 1 year 
(r = 0.422; p < 0.001).
Secondary endpoints
During 30 days, 194 (9.6%) patients were 
hospitalized regardless of the cause. One hundred 
and seventy-two patients were hospitalized once, 
20 — twice and 2 — three times. In total, all-cause 
hospitalization number was 218.
In 1-year follow-up, 747 patients were hospi-
talized regardless of cause (36.9%). Four hundred 
and thirty patients were hospitalized once, 169 — 
twice, 78 — 3 times, 72 — at least 4 times. There 
were 1,369 hospitalizations.
During a 1-year follow-up, 192 (9.5%) patients 
underwent subsequent AF/AFl ablations. In 165 
(86.0%) patients, 1 ablation was performed, in 26 
patients — 2 (13.5%) ablations, and in 1 patient — 
3 (0.5%) ablations (Table 4).
Table 3. Comparison between atrial fibrillation/flutter (AF/AFl) hospitalization group and no AF/AFl  
hospitalization group in a 1-year follow-up.
Hospitalization due  
to AF/AFl group  
N = 540 (26.7%)
No hospitalizations 
due to AF/AFl group  
N = 1,482 (73.3%)
P
Age 58.2 ± 10.9 58.8 ± 11.0 0.35
Duration of the primary hospitalization 4.06 ± 2.5 3.8 ± 2.7 0.001
Males 344 (63.7%) 1,007 (67.9%) 0.07
Radiofrequency ablation 423 (78.3%) 1,129 (76.2%) 0.311
Total mortality 7 (1.3%) 22 (1.5%) 0.753
Strokes 0 (0%) 7 (0.5%) 0.11
Thromboembolic events 1 (0.2%) 10 (0.7%) 0.185
Heart failure hospitalizations 16 (3.0%) 35 (2.3%) 0.446
Coronary disease hospitalizations 19 (3.5%) 41 (2.8%) 0.378
Hypertension hospitalizations 16 (2.9%) 11 (0.7%) < 0.001
Vascular hospitalizations 5 (0.9%) 11 (0.7%) 0.680
Number of patients with cardiovascular  
disease hospitalization (without AF/AFl)
52 (9.6%) 99 (6.7%) 0.026




Total number of hospitalizations 218
Total number of patients hospitalized 194 (9.6%)





Total number of hospitalizations 1,369
Total number of patients hospitalized 747 (36.9%)




at least four times 72
Repeat atrial fibrillation/flutter ablations
Number of repeat ablation  
in 1-year follow-up 192 (9.5%)
Number of patients with: 165 (85.9%)
1 repeat ablation
2 repeat ablation 26 (13.5%)
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Mortality
Twenty-nine (1.4%) patients died during the 
follow-up. Two patients died within 30 days from 
the index hospitalization. First patient was 
a 65-year-old male hospitalized 7 days during the 
index hospitalization. He died 22 days after dis-
charge. He was not hospitalized in the follow-up. 
Second patient was a 68-year-old male who was 
hospitalized 7 days during the index hospitalization. 
He was discharged to another center where he was 
hospitalized for 8 days because of AF/AFl. Sixteen 
days later he was admitted because of severe HF 
and he died 4 days after admission.
Patients who died in 1-year follow-up were older 
(66.0 ± 10.7 vs. 58.5 ± 10.9 years; p < 0.001) and 
their index hospitalization lasted longer (6.1 ± 5.3 vs. 
3.8 ± 2.6 days; p = 0.001). The hospitalization due 
to AF/AFl recurrence was not associated with higher 
1-year total mortality (1.3% vs. 1.5%; p = 0.753).
Subgroup analysis
Cryoballoon ablation vs. RF ablation. 
Cryoballoon ablation was performed in 470 (23.2%) 
patients; RF ablation was performed in 1,552 
(76.8%) patients. No difference in mortality, total 
hospitalization rate and specific hospitalization 
type was observed except from the number of 
hospitalizations in 30-day follow-up because of 
thromboembolic events (0.4% in cryoballoon abla-
tion vs. 0% in RF ablation; p = 0.01).
Men vs. women. There were 671 women 
and 1,351 men included in the study. Men were 
younger than women (57.3 ± 11.1 vs. 61.2 ± 10.1; 
p < 0.001). Hypertension hospitalizations were 
more frequent in female patients (2.2% vs. 0.9%; 
p = 0.013). We observed a trend towards more 
frequent AF/AFl hospitalization in 30-day follow-
up and a 1-year follow-up in female patients than 
male patients (7.5% vs. 5.4%; p = 0.070; 29.2% 
vs. 25.5%; p = 0.073). There were no differences 
regarding type of ablation (p = 0.574), as far as 
other endpoints between the groups are concerned.
Repeat ablation vs. no repeat ablation. 
Among patients rehospitalized because of AF/AFl 
(n = 540), a comparison was made between the 
ones who underwent subsequent ablation within 
a years’ time and the ones that did not. The pa-
tients who underwent another ablation were less 
frequently hospitalized due to AF in first 30 days 
(28/191, 14.7% vs. 95/349, 27.2%; p = 0.001) 
but more frequently in a years’ time (364/191 vs. 
524/349; p < 0.001). They also had less hospital-
ization in general in first 30 days (34/191, 17.8% 
vs. 106/349, 30.4%; p = 0.001). The patients that 
underwent the second ablation were younger 
(56.6 ± 10.98 vs. 59.11 ± 10.83; p = 0.019) and 
the time of the index hospitalization was shorter 
(3.75 ± 2.16 vs. 4.45 ± 3.26; p = 0.03). The type 
of initial ablation did not influence the decision 
about the second ablation (p = 0.529). There 
were no differences regarding mortality (2/191, 
1.0% in the repeat ablation group vs. 5/349, 1.4% 
in the no repeat ablation group; p = 0.705). Out 
of 196 women with recurrence of arrhythmia, 
54 underwent re-ablation and out of 344 men 137 had 
another procedure (27.6% vs. 39.8%; p = 0.005).
Multivariable analysis
In a logistic regression model age, length of 
initial hospitalization, number of hospitalization in 
1 year and all-cause hospitalization rate in 1 year 
influenced the risk of death but the model explained 
only 12.4% of observed differences. The probability 
of undergoing another ablation was influenced by 
age, sex, time of initial hospitalization, number of 
hospitalization due to AF in 30 days and in 1 year. 
This 5-step model explained 13.5% of observed dif-
ferences. An attempt to create a model predicting 
hospitalization in 1 year because of AF was made. 
With the factors included in this study only 1% of 
observed differences could be explained.
Discussion
In our large, unselected cohort of patients who 
underwent RF or cryoballoon AF/AFl ablation in 
Poland in 2012, 26.7% were hospitalized for AF/ 
/AFl recurrence in a 1-year follow-up and 6.1% in 
30-day follow-up. Close to 37% of patients were 
rehospitalized for any reason during 1 year and 
almost 10% during 30-day period. These results 
show that a repeat ablation is required in almost 
a tenth of the population. We observed 1.4% death 
rate in a 1-year follow-up.
Our results are comparable with these re-
ported in other registries [5, 6]. Shah et al. [5] 
identified 22% AF readmission rate and almost 
40% rehospitalization rate in AF ablation patients 
in California in a 1-year follow-up. In the same 
study, 30-day all-cause readmission rate was 10%. 
In the J-CARAF study, ablation was successful in 
approximately 70% of paroxysmal AF patients and 
60% of non-paroxysmal AF in a 1-year after the 
index procedure [6].
It should be assumed that the vast majority of 
hospitalization for arrhythmia recurrence was asso-
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ciated with symptomatic AF/AFl and asymptomatic 
AF is highly prevalent [7]. Therefore, a real rate 
of AF/AFl recurrence might be underestimated.
Prevalence of AF in general population is ris-
ing [1] and ablation procedures are more and more 
performed in symptomatic patients [2, 8], which is 
a result of widen indications to the procedure and 
a better availability of the ablation [4, 9]. It is worth 
to notice that AF ablation candidates are usually 
younger and have less comorbidities than general 
AF patients. This was also true in our cohort as the 
mean age of the studied population was 58.6 years 
and there were only 51 hospitalizations because of 
HF in the follow-up period. Apart from that, there 
is a clear demand on reduction the comorbidity 
rate, more effective arrhythmia treatment which 
might decrease the readmission rate of AF abla-
tion recipients.
Longer duration of initial hospitalization was 
one of the risk factors for AF/AFl rehospitaliza-
tion. The initial ablation was less successful in 
patients who were hospitalized subsequently due 
to cardiovascular reasons. Patients with AF/AFl 
hospitalizations within 30 days of index ablation 
were more frequently hospitalized due to HF within 
1 year from ablation. Those results might point to 
the fact that patients with AF/AFl recurrence after 
ablation have a greater burden of cardiovascular 
diseases especially hypertension and HF, which 
prolonged their initial hospitalization or that those 
disease are less successfully managed increasing 
the risk of AF/AFl relapse. Patients with AF/AFl 
hospitalization were more frequently hospital-
ized due to hypertension. This is also consistent 
with the fact that uncontrolled hypertension can 
promote AF.
It is worth noticing that patients who under-
went repeat ablation within 1 year were younger 
and their initial hospitalization time was shorter. 
This might suggest that more attention should be 
paid in patient qualification for the ablation proce-
dure. A screening for coronary artery disease and 
good control of HF risk factors as well as HF itself 
is highly needed. Interestingly, we observed gender 
discrepancies in making decision about reablation 
among patients with arrhythmia recurrence. Men 
underwent another ablation more frequently than 
women (39.8% vs. 27.6%; p = 0.005). One of the 
reasons explaining this phenomenon could be that 
women with recurrence of AF/AFl had worse con-
trol of AF/AFl risk factors. We observed that they 
were more frequently hospitalized due to hyper-
tension in 1 year. In our population, women were 
older at the time of initial ablation. This fact could 
also influence the qualification for repeat ablation. 
Forleo et al. [10] reported that women undergo-
ing AF ablation are older, have longer AF history 
and more comorbidities, however, they found no 
differences in AF recurrence compared with men. 
This observation is consistent with other results 
showing that women have higher rate of AF/AFl 
recurrence after cardioversion [11]. This is inter-
esting especially when compared with a suggestion 
of Kerr and Humphries [12] that successful inter-
ventional treatment might be particularly useful 
to improve the quality of life in women with AF.
Limitations of the study
The major limitation is the fact that our study 
group comprised of heterogeneous population of AF 
and AFl patients. The reason for this is that ICD-10 
classification is used to report main discharge diag-
nosis (I48 — atrial fibrillation and flutter) to NHF. 
Therefore, we were unable to identify homogenous 
patients with AF only. The administrative data from 
NHF that were used in this study lacked the details 
that are available in clinical trials and registries like 
type of AF, procedural technique, clinical course, 
medication usage, especially antithrombotic treat-
ment, and comorbidities. However, this limitation 
was counterbalanced by the fact that our data were 
not associated with a single center experience and 
allowed for the inclusion of more patients, espe-
cially ones who are not usually well represented 
in clinical trials. Moreover, we did not obtain data 
on previous AF ablation procedures. We did not 
incorporate typical 3-month blanking period used 
in clinical trials of AF patients undergoing catheter 
ablation, because aim of our study was to present 
all readmissions to hospital.
Conclusions
Over a 1 out of 4 patients who underwent AF/ 
/AFl ablation was hospitalized because of arrhyth-
mia recurrence in 1 year. Over one-third ablation 
recipients were hospitalized in 1-year follow-up. 
Almost 10% of all ablation patients underwent 
subsequent ablation within a year from the initial 
procedure. Patients qualified for another ablation 
procedure were younger and the time of the index 
hospitalization was shorter. Future studies should 
focus on novel methods of reducing arrhythmia 
recurrence and readmissions.
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